Nuveen Asset Management’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $797K | Hold |
169,549
| – | – | ﹤0.01% | 2805 |
|
|
2024
Q3 | $605K | Hold |
169,549
| – | – | ﹤0.01% | 2947 |
|
|
2024
Q2 | $1.05M | Buy |
+169,549
| New | +$1.05M | ﹤0.01% | 2706 |
|
|
2023
Q2 | – | Sell |
-288,737
| Closed | -$823K | – | 3222 |
|
|
2023
Q1 | $823K | Buy |
288,737
+35,012
| +14% | +$99.8K | ﹤0.01% | 2674 |
|
|
2022
Q4 | $1.85M | Buy |
253,725
+95,519
| +60% | +$695K | ﹤0.01% | 2424 |
|
|
2022
Q3 | $1.28M | Sell |
158,206
-242,936
| -61% | -$1.97M | ﹤0.01% | 2634 |
|
|
2022
Q2 | $1.97M | Buy |
401,142
+109,810
| +38% | +$538K | ﹤0.01% | 2442 |
|
|
2022
Q1 | $4.97M | Sell |
291,332
-88,314
| -23% | -$1.51M | ﹤0.01% | 2063 |
|
|
2021
Q4 | $5.97M | Buy |
379,646
+247,768
| +188% | +$3.9M | ﹤0.01% | 2021 |
|
|
2021
Q3 | $4.07M | Buy |
131,878
+15,847
| +14% | +$488K | ﹤0.01% | 2323 |
|
|
2021
Q2 | $1.22M | Sell |
116,031
-27,171
| -19% | -$285K | ﹤0.01% | 2938 |
|
|
2021
Q1 | $1.69M | Buy |
143,202
+25,448
| +22% | +$300K | ﹤0.01% | 2695 |
|
|
2020
Q4 | $1.38M | Buy |
117,754
+67,598
| +135% | +$792K | ﹤0.01% | 2678 |
|
|
2020
Q3 | $397K | Buy |
50,156
+794
| +2% | +$6.29K | ﹤0.01% | 3011 |
|
|
2020
Q2 | $902K | Buy |
49,362
+13,532
| +38% | +$247K | ﹤0.01% | 2659 |
|
|
2020
Q1 | $428K | Buy |
+35,830
| New | +$428K | ﹤0.01% | 2818 |
|